Ethaselen | m-entrepreneurship.com

Product Name :
Ethaselen

Search keywords :
Ethaselen

drugId :
null

Target Vo:
Thioredoxin reductase

Target Vo Short Name :
TrxR

Moa_Name:
Thioredoxin reductase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Peking University

Active Company_Name :
Cheezheng Tibetan Medicine Co Ltd

Active Indication_Name:
Hematologic Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Calnexin Rabbit mAb supplier
COX IV Rabbit mAb Data Sheet
p53 (acetyl K382) Antibody: p53 (acetyl K382) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 53 kDa, targeting to p53 (acetyl K382). It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts